Relaxera and CBL Patras announce exclusive agreement on manufacturing and sales of synthetic human relaxin-2.
This cooperation agreement designates CBL as the exclusive manufacturing partner for synthetic human relaxin-2 (GMP and non-GMP) and Relaxera as the exclusive sales executive partner for relaxin.
A cooperation for easier access for continued research in the ‘relaxin community’ world
